Anti-VEGF Treatment of Corneal Neovascularization

Author： Keating Anne M.   Jacobs Deborah S.  

Publisher： Ethis Communications

ISSN： 1542-0124

Source： The Ocular Surface, Vol.9, Iss.4, 2011-10, pp. : 227-238

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration

By  

Current Drug Targets, Vol. 12, Iss. 2, 2011-01 ,pp. : 173-181

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance to Anti-VEGF Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 1, 2004-01 ,pp. : 51-64

Bentham Science Publishers

Access to resources Recommend Favorite

Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 6, 2011-12 ,pp. : 497-508

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Therapy for Retinal Vein Occlusions

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 328-336

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-VEGF Molecules for the Management of Diabetic Macular Edema

By  

Current Pharmaceutical Design, Vol. 21, Iss. 32, 2015-10 ,pp. : 4731-4737

Bentham Science Publishers

Access to resources Recommend Favorite